TAIKO PHARMACEUTICAL CO.,LTD.

4574・Prime Market・Pharmaceuticals

Official website

TAIKO PHARMACEUTICAL CO.,LTD.

4574・Prime Market・Pharmaceuticals

Official website

TAIKO PHARMACEUTICAL CO.,LTD.4574

Reference Indicators

Market Cap

138¥100M

P/E (Forecast)

24.9x

P/B

1.6x

Dividend Yield (Forecast)

1.28%

ROE

11.2%

EV/EBITDA

14.3x

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	11,299	5,040	6,120	6,292	6,397
Cost of Sales	7,973	3,961	3,543	2,626	2,916
Gross Profit	3,325	1,078	2,577	3,666	3,481
SG&A Expenses	7,694	4,157	3,583	3,036	3,022
Operating Income	-4,947	-3,079	-1,005	629	459
Non-operating Income	108	109	82	86	37
Non-operating Expenses	1,292	383	325	28	14
Ordinary Income	-6,131	-3,352	-1,248	688	482
Extraordinary Income	60	—	298	210	502
Extraordinary Losses	2,817	1,516	2,613	333	27
Pre-tax Income	-8,887	-4,869	-3,563	565	958
Income Taxes	706	25	47	-332	34
Net Income	-9,594	-4,895	-3,611	898	923
EBITDA	-4,006	-2,342	-301	885	724
Gross Margin	29.4%	21.4%	42.1%	58.3%	54.4%
Operating Margin	-43.8%	-61.1%	-16.4%	10.0%	7.2%
ROA	-42.6%	-32.5%	-27.3%	7.0%	7.5%
ROE	-53.9%	-47.0%	-48.9%	12.2%	11.2%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医薬品事業	5,771	1,573	27.3%
感染管理事業	619	-254	-41.0%
その他	5	-22	-440.0%